{"nct_id":"NCT01564784","title":"A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia","status":"COMPLETED","status_verified_date":"2018-12","start_date":"2012-08-02","start_date_type":"ACTUAL","primary_completion_date":"2016-03-08","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}